KLP Kapitalforvaltning AS bought a new position in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 41,475 shares of the company's stock, valued at approximately $962,000.
Other hedge funds also recently bought and sold shares of the company. UMB Bank n.a. lifted its holdings in shares of Option Care Health by 41.7% during the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock valued at $27,000 after purchasing an additional 346 shares in the last quarter. Signaturefd LLC lifted its stake in Option Care Health by 487.9% in the fourth quarter. Signaturefd LLC now owns 1,211 shares of the company's stock valued at $28,000 after buying an additional 1,005 shares in the last quarter. Quarry LP lifted its stake in Option Care Health by 327.7% in the third quarter. Quarry LP now owns 3,430 shares of the company's stock valued at $107,000 after buying an additional 2,628 shares in the last quarter. Blue Trust Inc. boosted its holdings in shares of Option Care Health by 16.9% in the fourth quarter. Blue Trust Inc. now owns 4,703 shares of the company's stock valued at $109,000 after buying an additional 681 shares during the period. Finally, Venturi Wealth Management LLC increased its position in shares of Option Care Health by 2,621.3% during the fourth quarter. Venturi Wealth Management LLC now owns 4,735 shares of the company's stock worth $110,000 after acquiring an additional 4,561 shares in the last quarter. 98.05% of the stock is currently owned by institutional investors and hedge funds.
Option Care Health Price Performance
Shares of OPCH stock traded down $1.40 on Friday, reaching $33.54. The company had a trading volume of 2,392,435 shares, compared to its average volume of 1,729,252. The business's 50-day moving average is $32.97 and its 200 day moving average is $28.53. Option Care Health, Inc. has a one year low of $21.39 and a one year high of $35.53. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The stock has a market capitalization of $5.51 billion, a PE ratio of 28.18, a price-to-earnings-growth ratio of 2.30 and a beta of 1.07.
Insider Activity at Option Care Health
In other news, insider Michael Bavaro sold 30,996 shares of the company's stock in a transaction on Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the completion of the transaction, the insider now directly owns 44,974 shares in the company, valued at approximately $1,495,835.24. This represents a 40.80 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.64% of the stock is owned by insiders.
Analyst Ratings Changes
A number of research analysts recently issued reports on OPCH shares. Bank of America upgraded Option Care Health from a "neutral" rating to a "buy" rating and increased their price objective for the stock from $26.00 to $33.00 in a report on Monday, January 13th. Jefferies Financial Group raised shares of Option Care Health from a "hold" rating to a "buy" rating and boosted their price objective for the company from $26.00 to $35.00 in a report on Thursday, January 23rd. JPMorgan Chase & Co. raised their price objective on Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a research note on Thursday, March 6th. Barrington Research increased their target price on Option Care Health from $33.00 to $38.00 and gave the stock an "outperform" rating in a report on Thursday, February 27th. Finally, UBS Group started coverage on Option Care Health in a research note on Thursday, December 5th. They issued a "neutral" rating and a $26.00 price target for the company. Two investment analysts have rated the stock with a hold rating and six have given a buy rating to the company's stock. According to data from MarketBeat.com, Option Care Health presently has an average rating of "Moderate Buy" and a consensus target price of $33.00.
Get Our Latest Report on OPCH
About Option Care Health
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Featured Articles
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
